Dr. Calvin Christopher Brown, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6760 Goodman Rd Ste 125, Olive Branch, MS 38654 Phone: 901-682-1100 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.
Scientists under the leadership of the University of Bonn have harnessed rabies viruses for assessing the connectivity of nerve cell transplants: coupled with a green fluorescent protein, the viruses show where replacement cells engrafted into mouse brains have connected to the host neural network.
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
For the first time, a variant in UBQLN4 gene has been associated with Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS) - a progressive disease resulting in the loss of nerve cells that control muscle movement, which eventually leads to paralysis and death.
WellCare officials on Monday announced that the health insurer has revised financial statements from 2004 through mid-2007 to include refunds owed to the Florida and Illinois Medicaid programs, the St. Petersburg Times reports (Hundley, St. Petersburg Times, 7/21).
› Verified 1 days ago